Skip to Main Content

Paper Details

Short-term outcomes of switching to brolucizumab in japanese patients with neovascular age-related macular degeneration.
Jpn J Ophthalmol
9
2022
Author NameAffiliation
Yasuo YanagiYokohama City University Medical Center
  • 1 - 1

Datasets

Release 1.2